The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_004360.5(CDH1):c.1590dup (p.Asn531fs)

CA658658491

449339 (ClinVar)

Gene: CDH1
Condition: hereditary diffuse gastric cancer
Inheritance Mode: Autosomal dominant inheritance
UUID: 552d88d5-40c6-4f5f-a451-3c5da270c6db
Approved on: 2020-06-16
Published on: 2020-09-16

HGVS expressions

NM_004360.5:c.1590dup
NM_004360.5(CDH1):c.1590dup (p.Asn531fs)
NC_000016.10:g.68819304dup
CM000678.2:g.68819304dup
NC_000016.9:g.68853207dup
CM000678.1:g.68853207dup
NC_000016.8:g.67410708dup
NG_008021.1:g.87013dup
ENST00000261769.10:c.1590dup
ENST00000261769.9:c.1590dup
ENST00000422392.6:c.1407dup
ENST00000562836.5:n.1661dup
ENST00000566510.5:c.*256dup
ENST00000566612.5:c.1566-2697dup
ENST00000611625.4:c.1653dup
ENST00000612417.4:c.1590dup
ENST00000621016.4:c.1590dup
NM_004360.3:c.1590dup
NM_001317184.1:c.1407dup
NM_001317185.1:c.42dup
NM_001317186.1:c.-254-2697dup
NM_004360.4:c.1590dup
NM_001317184.2:c.1407dup
NM_001317185.2:c.42dup
NM_001317186.2:c.-254-2697dup
More

Pathogenic

Met criteria codes 3
PS4_Supporting PVS1 PM2
Not Met criteria codes 23
PP1 PP2 PP3 PP4 BS1 BS4 BS3 BS2 BP5 BP7 BP4 BP3 BP1 BP2 PM1 PM3 PM5 PM4 PS1 PS2 PS3 BA1 PM6

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
CDH1 VCEP
The c.1590dup (p.Asn531fs) variant is predicted to result in a premature stop codon that leads to a truncated or absent protein (PVS1). The variant is absent in the gnomAD cohort (PM2; http://https://gnomad.broadinstitute.org/). This variant has been reported in a family meeting HDGC clinical criteria (PS4_Supporting, PMID: 10477433). In summary, this variant meets criteria to be classified as Pathogenic based on the ACMG/AMP criteria applied as specified by the CDH1 Variant Curation Expert Panel: PVS1, PM2, PS4_Supporting.
Met criteria codes
PS4_Supporting
variant identified in a family meeting HDGC clinical criteria (proband and mother with signet cell adenocarcinoma diagnosed at 40 and 48, respectively) (PMID: 10477433)

PVS1
Duplication results in a frameshift which creates a premature stop codon at position 6 of the new reading frame (position 536 in mutant sequence)
PM2
Variant not present in gnomAD
Not Met criteria codes
PP1
applied PS4 instead; sequencing confirmed presence of the variant in 3 affected individuals (proband, mother, maternal aunt) in one family (PMID: 10477433)
PP2
variant is predicted to result in a premature stop codon that leads to a truncated or absent protein
PP3
variant is predicted to result in a premature stop codon that leads to a truncated or absent protein
PP4
Use PS4 in place of PP4
BS1
Variant not present in gnomAD
BS4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP7
variant is predicted to result in a premature stop codon that leads to a truncated or absent protein
BP4
variant is predicted to result in a premature stop codon that leads to a truncated or absent protein
BP3
variant is predicted to result in a premature stop codon that leads to a truncated or absent protein
BP1
variant is predicted to result in a premature stop codon that leads to a truncated or absent protein
BP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM1
Do not use for this gene
PM3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM5
variant is predicted to result in a premature stop codon that leads to a truncated or absent protein
PM4
variant is predicted to result in a premature stop codon that leads to a truncated or absent protein
PS1
variant is predicted to result in a premature stop codon that leads to a truncated or absent protein
PS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BA1
Variant not present in gnomAD
PM6
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.